FDA OKs Warner Chilcott's Atelvia for postmenopausal osteoporosis

10/11/2010 | Reuters

The FDA has approved Atelvia, Warner Chilcott's treatment for osteoporosis in postmenopausal women. The delayed-release tablet belongs to the Actonel family of bone drugs that Warner Chilcott purchased last year from Procter & Gamble.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD